Comprehensive Eye Exams

The Early Detection of Vision Impairment in Children (EDVI) Act was recently introduced in the US House of Representatives with the goal of improving access, diagnosis, and treatment for children ages 2 to 17, according to Prevent Blindness.

Honest discussions about treatments for dry eye disease can enhance compliance and simplify care.

Selina McGee, OD, FAAO, shares an overview of a panel on Thyroid Eye Disease that took place at Controversies in Modern Eye Care.

The important role eye care providers play in lessening the burden of myopia treatment for pediatric specialists.

Phentolamine ophthalmic solution 0.75% is a preservative-free, stable eye drop, which blocks the α1 receptor within the iris dilator muscle without affecting the ciliary muscle.

One of the 15 clinics Miriam Korik, OD, works at is an optical boutique. She shares her expertise on exam personalization and how to realize these tweaks as sales.

The company’s inSights Research Program found that an increase in eye exams and prescription eye care products sold in 2023 resulted in slight industry growth.

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.

How to tailor an eye examination and what technology to consider.

Phentolamine ophthalmic solution 0.75%, or Nyxol, receives a PDUFA date of September 28, 2023, for the indication of reversal of pharmacologically induced mydrasis.

The VEGA-2 pivotal trial is investigating Nyxol alone and Nyxol with adjunctive low-dose pilocarpine therapy for the treatment of presbyopia.

Ocuphire seeks to develop and commercialize Nyxol for the reversal of mydriasis, presbyopia and night vision disturbances.